Real-world (RW) systemic treatment patterns and clinical outcomes in locally advanced (LA) and recurrent or metastatic (R/M) cutaneous squamous cell carcinoma (cSCC) patients (pts).

被引：0
|
作者：
Thao Vo
Boyd, Marley
Espirito, Janet L.
Gumuscu, Burak
Chirovsky, Diana Romana
Robert, Nicholas J.
Swaby, Ramona F.
Zhou, Wei
Cowey, Charles Lance
机构：
[1] Merck, Kenilworth, NJ USA
[2] McKesson Life Sci, The Woodlands, TX USA
[3] Merck & Co Inc, Kenilworth, NJ USA
[4] Merck & Co Inc, Jersey City, NJ USA
[5] Baylor Sammons Canc Ctr TOPA, Frisco, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19284
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Assessment of treatment patterns and real-world outcomes following changes in the treatment paradigm for locally advanced/metastatic urothelial carcinoma (la/mUC) in the US.
    Kirker, Melissa
    Abraham, Anup
    Vlahiotis, Anna
    Bhanegaonkar, Abhijeet
    Benjumea, Darrin
    Kim, Chai
    Sun, Haiyan
    Kearney, Mairead
    Chandrasekar, Sanjana
    Li, Benjamin
    Thakkar, Sheena
    Moon, Helen H.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [42] CemiplimAb-rwlc Survivorship and Epidemiology (CASE): A prospective study of the safety and efficacy of cemiplimab in patients (pts) with advanced cutaneous squamous cell carcinoma (CSCC) in a real-world setting
    Rabinowits, G.
    Homsi, J.
    Park, S. J.
    Khushanlani, N.
    Panella, T.
    Ellison, D. M.
    Gentry, R. W.
    Venna, S. S.
    Strasswimmer, J.
    Zuniga, R. M.
    Chandra, S.
    Ruiz, E. S.
    Migden, M. R.
    Ibrahim, S.
    Mehta, N.
    He, X.
    Zhang, H.
    Gillis, K. A.
    Pouliot, J-F.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S925 - S926
  • [43] Avelumab first-line maintenance (1LM) for locally advanced or metastatic urothelial carcinoma (la/mUC): Treatment (tx) patterns and real-world (rw) outcomes in the US
    Carson, K.
    Mahmoudpour, H.
    Ike, C.
    Monzon, S.
    Fragkogianni, S.
    Ferrer, J.
    Kearney, M.
    ANNALS OF ONCOLOGY, 2023, 34 : S1215 - S1216
  • [44] Treatment patterns and clinical outcomes of newly diagnosed locally advanced head and neck squamous cell carcinoma (LA HNSCC): A retrospective cohort analysis of national real-world data in England
    Black, Chris M.
    Kong, Anthony
    Chiu, Gavin
    Bolodeoku, John
    Massey, Olivia
    Patel, Amisha
    Ford, Alexander
    Holbrook, Tim
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [45] Targeted Therapy in Locally Advanced and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (LA-R/M HNSCC)
    Jose Echarri, Maria
    Lopez-Martin, Ana
    Hitt, Ricardo
    CANCERS, 2016, 8 (03)
  • [46] Real-world first-line treatment patterns and outcomes in patients with locally advanced or metastatic urothelial carcinoma in the United States.
    Chen, Ronald C.
    Mucha, Lisa
    Nimke, David
    Young, Christopher
    Yang, Hongbo
    Liu, Qing
    Greatsinger, Alexandra
    Zhang, Adina
    Wright, Phoebe
    Quicquaro, Christina Marie
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [47] Real-world outcomes treating patients with advanced cutaneous squamous cell carcinoma with immune checkpoint inhibitors (CPI)
    Hanna, Glenn J.
    Ruiz, Emily S.
    LeBoeuf, Nicole R.
    Thakuria, Manisha
    Schmults, Chrysalyne D.
    Decaprio, James A.
    Silk, Ann W.
    BRITISH JOURNAL OF CANCER, 2020, 123 (10) : 1535 - 1542
  • [48] Cemiplimab in advanced cutaneous squamous cell carcinoma: A real-world experience of outcomes and safety.
    Badami, Sunil
    Mazloom, Anita
    Howard, John Harrison
    Liles, J. Spencer
    Alkharabsheh, Omar
    Persing, Brian Edward
    Cameron, Daniel
    Huddleston, Adam
    Gilbert, Robert
    Venkatesh, Kshithi
    Prodduturvar, Pranitha
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [49] Real-world outcomes treating patients with advanced cutaneous squamous cell carcinoma with immune checkpoint inhibitors (CPI)
    Glenn J. Hanna
    Emily S. Ruiz
    Nicole R. LeBoeuf
    Manisha Thakuria
    Chrysalyne D. Schmults
    James A. Decaprio
    Ann W. Silk
    British Journal of Cancer, 2020, 123 : 1535 - 1542
  • [50] Real-world (rw) treatment (tx) patterns, sequencing, and outcomes in US patients (pts) with locally advanced or metastatic urothelial cancer (la/mUC) treated with avelumab first-line maintenance (1LM)
    Carson, Kenneth Robert
    Ike, Chiemeka
    Mahmoudpour, Seyed Hamidreza
    Monzon, Sebastian
    Fragkogianni, Stamatina
    Kearney, Mairead
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345